4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001234066-04-000004
President and CEO sold 32,450 shares at $6.87 ($222,932)
- President and CEO acquired 32,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HARRIS ROBERT B President and CEO | 2004-03-12 | Option exercise | +25,381 | 76,502 | D | ||
| HARRIS ROBERT B President and CEO | 2004-03-12 | Option exercise | +7,069 | 83,571 | D | ||
| HARRIS ROBERT B President and CEO | 2004-03-12 | Sale | −25,381 | $6.87 | $174,367 | 58,190 | D |
| HARRIS ROBERT B President and CEO | 2004-03-12 | Sale | −7,069 | $6.87 | $48,564 | 51,121 | D |
| Derivatives | |||||||
| HARRIS ROBERT B President and CEO | 2004-03-12 | Option exercise · Stock Options | −25,381 | 126,529 | D | ||
| HARRIS ROBERT B President and CEO | 2004-03-12 | Option exercise · Stock Options | −7,069 | 119,460 | D | ||
| Open-market sales · 32,450 sh · avg $6.87 · $222,932 | |||||||
Loading xslF345X02/primary_doc.xml…